NCT05362058 A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time Status COMPLETED Phase PHASE3
NCT05341102 A Study of Single and Repeated Doses of LY3556050 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05341089 A Study of Two Different Formulations of LY3502970 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05338515 A Study of Selpercatinib (LY3527723) in Healthy Participants Status COMPLETED Phase PHASE1
NCT05338502 Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants Status COMPLETED Phase PHASE1
NCT05338489 A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants Status COMPLETED Phase PHASE1
NCT05338476 A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants Status COMPLETED Phase PHASE1
NCT05327595 A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT05325294 Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev® Status COMPLETED Phase NA
NCT05324124 A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participants Status COMPLETED Phase PHASE1
NCT05313802 A Study of LY3502970 in Healthy Overweight and Obese Participants Status COMPLETED Phase PHASE1
NCT05307705 A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05305924 Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT05300932 A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05295940 A Study of LY3841136 in Healthy and Overweight Participants Status COMPLETED Phase PHASE1
NCT05288166 A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05275400 A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin Status COMPLETED Phase PHASE3
NCT05267327 A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast Status NOT_YET_RECRUITING Phase N/A
NCT05263505 Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid Status TERMINATED Phase PHASE2